Staging IV NSCLC
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Rh-endostatin Combined With Chemotherapy and Pembrolizumab for Advanced NSCLC (NCT04094909) | Guangzhou Institute of Respiratory Disease | 2020-02-06 |
Track Staging IV NSCLC automatically
Every clearance here is in the API, with alerts when new ones post.